Correlation Between United Therapeutics and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both United Therapeutics and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining United Therapeutics and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between United Therapeutics and Nuvectis Pharma, you can compare the effects of market volatilities on United Therapeutics and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in United Therapeutics with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of United Therapeutics and Nuvectis Pharma.
Diversification Opportunities for United Therapeutics and Nuvectis Pharma
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between United and Nuvectis is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding United Therapeutics and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and United Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on United Therapeutics are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of United Therapeutics i.e., United Therapeutics and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between United Therapeutics and Nuvectis Pharma
Given the investment horizon of 90 days United Therapeutics is expected to generate 1.01 times less return on investment than Nuvectis Pharma. But when comparing it to its historical volatility, United Therapeutics is 3.53 times less risky than Nuvectis Pharma. It trades about 0.11 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 740.00 in Nuvectis Pharma on November 9, 2024 and sell it today you would lose (16.00) from holding Nuvectis Pharma or give up 2.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
United Therapeutics vs. Nuvectis Pharma
Performance |
| Timeline |
| United Therapeutics |
| Nuvectis Pharma |
United Therapeutics and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with United Therapeutics and Nuvectis Pharma
The main advantage of trading using opposite United Therapeutics and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if United Therapeutics position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| United Therapeutics vs. Incyte | United Therapeutics vs. Alnylam Pharmaceuticals | United Therapeutics vs. Ultragenyx | United Therapeutics vs. Apellis Pharmaceuticals |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |